{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:58:49Z","timestamp":1789984729669,"version":"4.0.1"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T00:00:00Z","timestamp":1508284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0186380","type":"journal-article","created":{"date-parts":[[2017,10,18]],"date-time":"2017-10-18T17:44:26Z","timestamp":1508348666000},"page":"e0186380","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development and characterization of novel chimeric monoclonal antibodies for broad spectrum neutralization of rabies virus"],"prefix":"10.1371","volume":"12","author":[{"given":"Pan Kyeom","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0498-2366","authenticated-orcid":true,"given":"Sun Ju","family":"Keum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modupe O. V.","family":"Osinubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Franka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Tae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man Su","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengcheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Lihua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhusdana","family":"Shampur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin Jae","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,10,18]]},"reference":[{"key":"ref1","first-page":"13","article-title":"Rabies review: immunopathology, clinical aspects and treatment","author":"CA Consales","year":"2007","journal-title":"J. Venom. Anim. Toxins"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.3201\/eid0912.030374","article-title":"Novel lyssaviruses isolated from bats in Russia","volume":"9","author":"DA Botvinkin","year":"2003","journal-title":"Emerg. Infect. Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1017\/S0950268803001481","article-title":"European bat lyssaviruses: an emerging zoonosis","volume":"131","author":"AR Fooks","year":"2003","journal-title":"Epidemiol. Infect"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0168-1702(03)00217-X","article-title":"Bat lyssaviruses (Aravan and Khujand) from Central Asia: phylogenetic relationships according to N, P and G genes sequences","volume":"97","author":"VI Kuzmin","year":"2003","journal-title":"Virus Res"},{"key":"ref5","first-page":"1","article-title":"Expert Consultation on Rabies. Second report","volume":"982","year":"2013","journal-title":"World Health Organ Tech Rep Ser"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"184","DOI":"10.12688\/f1000research.10416.1","article-title":"Lyssaviruses and rabies: current conundrums, concerns, contradictions and controversies","volume":"6","author":"C Rupprecht","year":"2017","journal-title":"F1000Res"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1474-4422(02)00041-8","article-title":"Human rabies: a disease of complex neuropathogenic mechanism and diagnostic challenges","volume":"1","author":"T Hemachudha","year":"2002","journal-title":"Lancet Neurol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0140-6736(04)15792-9","article-title":"Rabies and other lyssavirus diseases","volume":"363","author":"MJ Warrell","year":"2004","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.3201\/eid1112.050271","article-title":"Pivotal role of dogs in rabies transmission, China","volume":"11","author":"X Tang","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(02)00287-6","article-title":"Rabies re-examined","volume":"2","author":"CE Rupprecht","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","article-title":"Estimating the global burden of endemic canine rabies","volume":"9","author":"K Hampson","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"ref12","first-page":"360","article-title":"Re-evaluating the burden of rabies in Africa and Asia","volume":"83","author":"DL Knobel","year":"2005","journal-title":"Bull World Health Organ"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e542","DOI":"10.1371\/journal.pntd.0000542","article-title":"Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans","volume":"3","author":"T M\u00fcller","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref14","unstructured":"World Health Organization. Guide for post-exposure prophylaxis. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/rabies\/human\/postexp\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/rabies\/human\/postexp\/en\/<\/ext-link>"},{"key":"ref15","first-page":"731","article-title":"Purified equine rabies immune globulin: a safe and affordable alternative to human rabies immune globulin","volume":"67","author":"H Wilde","year":"1989","journal-title":"Bull World Health Organ"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1056\/NEJMcp042140","article-title":"Clinical practice. Prophylaxis against rabies","volume":"351","author":"CE Rupprecht","year":"2004","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0264-410X(89)90003-0","article-title":"Adverse effects of equine rabies immune globulin","volume":"7","author":"H Wilde","year":"1989","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.trstmh.2006.04.009","article-title":"Sex- and age-related differences in rabies immunoglobulin hypersensitivity","volume":"101","author":"K Suwansrinon","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-1759(99)00223-9","article-title":"The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure","volume":"235","author":"JM Champion","year":"2000","journal-title":"J Immunol Methods"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1128\/JVI.64.6.3087-3090.1990","article-title":"Biological characterization of human monoclonal antibodies to rabies virus","volume":"64","author":"B Dietzschold","year":"1990","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/375247","article-title":"Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies","volume":"188","author":"M Prosniak","year":"2003","journal-title":"J Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1128\/JVI.79.8.4672-4678.2005","article-title":"Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis","volume":"79","author":"WE Marissen","year":"2005","journal-title":"J Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1128\/JVI.79.14.9062-9068.2005","article-title":"Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants","volume":"79","author":"AB Bakker","year":"2005","journal-title":"J Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1086\/500470","article-title":"Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin","volume":"193","author":"J Goudsmit","year":"2006","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.62.1.1-7.1988","article-title":"Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence","volume":"62","author":"C Prehaud","year":"1988","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1099\/0022-1317-64-4-843","article-title":"Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies","volume":"64","author":"M Lafon","year":"1983","journal-title":"J Gen Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/JVI.53.3.926-934.1985","article-title":"Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein","volume":"53","author":"I Seif","year":"1985","journal-title":"J Virol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1099\/0022-1317-70-2-291","article-title":"Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein","volume":"70","author":"H Bunschoten","year":"1989","journal-title":"J Gen Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/JVI.65.8.4198-4203.1991","article-title":"Antigenicity of rabies virus glycoprotein","volume":"65","author":"A Benmansour","year":"1991","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1128\/JVI.79.8.4672-4678.2005","article-title":"Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis","volume":"79","author":"WE Marissen","year":"2005","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"037","DOI":"10.4172\/jaa.1000061","article-title":"Conservation of binding epitopes for monoclonal antibodies on the rabies virus glycoprotein","volume":"5","author":"NA Kuzmina","year":"2013","journal-title":"J Antivir Antiretrovir"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1096\/fj.12-219964","article-title":"Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans","volume":"27","author":"L Both","year":"2013","journal-title":"FASEB J"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.antiviral.2011.06.002","article-title":"G glycoprotein amino acid residues required for human monoclonal antibody RAB1 neutralization are conserved in rabies virus street isolates","volume":"91","author":"Y Wang","year":"2011","journal-title":"Antiviral Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1016\/j.vaccine.2006.12.031","article-title":"Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates","volume":"25","author":"SE Sloan","year":"2007","journal-title":"Vaccine"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1073\/pnas.80.1.70","article-title":"Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus","volume":"80","author":"B Dietzschold","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.med.58.061705.145053","article-title":"A human monoclonal antibody cocktail as a novel component of rabies post-exposure prophylaxis","volume":"58","author":"J De Kruif","year":"2007","journal-title":"Annu Rev Med"},{"key":"ref37","first-page":"535","article-title":"A rapid reproducible test for determining rabies neutralizing antibody","volume":"48","author":"JS Smith","year":"1973","journal-title":"Bull World Health Organ"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-1759(97)00212-3","article-title":"Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody","volume":"212","author":"F Cliquet","year":"1998","journal-title":"J Immunol Methods"},{"key":"ref39","unstructured":"World Health Organization. WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against rabies; 1997. Available from: WHO\/EMC\/ZOO\/96.6."},{"key":"ref40","article-title":"Laboratory techniques in rabies","author":"FX Meslin","year":"1996"},{"key":"ref41","article-title":"WHO consultation on a rabies monoclonal antibody cocktail for rabies post exposure treatment","year":"2002"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"407","DOI":"10.15252\/emmm.201505986","article-title":"Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis","volume":"8","author":"P De Benedictis","year":"2016","journal-title":"EMBO Mol Med"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0186380","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,20]],"date-time":"2020-10-20T03:10:37Z","timestamp":1603163437000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0186380"}},"subtitle":[],"editor":[{"given":"Florian","family":"Krammer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,18]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0186380","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,18]]}}}